RATIONALE: Asthma control reflects the overall management of underlying airway inflammation. The purpose of this quality improvement project was to assess the feasibility of integrating the Asthma Control Test (ACT) into an urban residency based internal medicine clinic to reliably and consistently assess asthma control at all visit types. METHODS: Patients 18 years of age or older were prompted to selfidentify as having asthma by signs located in exam rooms. The ACT questionnaires were placed adjacent to those signs. Providers gave completed questionnaires to a designated medical assistant who uploaded them into the electronic medical record. A Plan-Do-Study-Act (PDSA) cycle was developed to guide the integration process. An electronic survey asked residents about their utilization of the ACT in clinic at the end of the seventh month. A goal was set for a 20% completion rate of the ACT. RESULTS: Seven months after the introduction of the questionnaires, 40 ACT were collected out of the 432 patients with asthma that attended clinic appointments, resulting in a 9.3% completion rate. The electronic survey reported that 68.97% of residents did not use the ACT, with lack of familiarity with the questionnaire (33.3%), time constraints (33.3%) and forgetting to use it (33.3%) as prevailing rationales. CONCLUSIONS: We demonstrated that the integration of the ACT into a resident clinic is feasible, but requires a multifaceted approach. Next steps are to develop additional PDSA cycles to address the challenges that arose, such as provider education and efficiency in clinic workflow, to reach the completion goal.
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The Effect of a Five-Day Educational Program for Children with Asthma on Airway Inflammatio Jinny Chang, Myron Liebhaber, and Gary Moreno; R.N., Sansum Medical Foundation, Santa Barbara, CA. RATIONALE: The aim of this study was to investigate the effectiveness of a 5 day educational program in children with asthma on airway inflammation as measured by FeNO. METHODS: Fifty-one children with asthma were enrolled in Camp Wheez. Written consent was obtained for each participant. Children were educated on the early signs of asthma, identifying triggers and the use of controller medication. The curriculum was provided by the asthma camp consortium by AAAAI. The NIOX VERO was used as a 6 to 10 second, single breath, quantitative measurement. We measured FeNO on day one (baseline) and day 5 (end of camp.) RESULTS: Fifty-one children were enrolled in the study with an average age 6-17 years.(range 6-17) Baseline determinations were done on day one and end of camp determinations were done on day 5. The baseline FeNO was 36.3 ppb, compared to 33.1 ppb at the end of camp. The average FeNo levels were the same at day 1 and 5 in campers with a low (<20 ppb) and intermediate However, in 21 campers with high baseline at >35 ppb (average 75 ppb), there was a 10% improvement at the end of camp at 67.5 (p5.001). None of the campers were informed on their baseline levels or received individual coaching. CONCLUSIONS: This study demonstrated the effectiveness of a 5-day asthma education program on 50 children with asthma. Our results showed a significant improvement in FeNO with a 10% improvement (significance at P<.001)at the conclusion of asthma education. University Hospital Frankfurt, Frankfurt, Germany. RATIONALE: Peanut allergy (PA) is usually lifelong and known to affect quality of life (QoL). The APPEAL study evaluated the psycho-social impact of PA on patients and their parents/caregivers. METHODS: APPEAL was a quantitative European online 30-minute survey, conducted in 8 European countries (Denmark, France, Germany, Ireland, Italy, Netherlands, Spain, UK). Adults with PA and parents/ caregivers of individuals with PA were eligible to participate in the study (self-report). Parents/caregivers could also fill out a questionnaire on behalf of PA individuals for whom they cared. RESULTS: A total of 1846 responses were analyzed. 1300 participants completed the survey: adults with PA (n5419, self-reporting), and parents/ caregivers of a person with PA (n5881, self-reporting). Sixty-two percent of parents/caregivers also completed a questionnaire, on behalf of a PA individual (n5546, proxy-reporting). 39.8% (n5735) felt frequently or very frequently frustrated by the limitations and restrictions of living with PA, and 28.2% (n5521) reported being somewhat frequently frustrated. Furthermore, 39.9% (n5736) reported high or extremely high level of uncertainty of living with PA. Regarding the stress due to living with PA, 39.9% (n5737) experienced an extremely high or high level of stress. These findings are consistent through the different European countries. CONCLUSIONS: APPEAL, the first multidimensional pan-European online survey, specifically designed to study the psycho-social burden of PA on individuals' lives and on their families, revealed that across the European countries studied, participants are experiencing a high level of frustration, stress, and uncertainty in everyday life when managing their PA using avoidance.
